Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

ziftomenib

KOMZIFTI

ziftomenib (KOMZIFTI) is an FDA-listed pharmaceutical active ingredient. Associated with Kura Oncology. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 20
Pipeline programs 12
News articles 0
Drug details — ziftomenib
US status
approved
Class
—
Route
ORAL
Patents
20
Programs
12
Data quality
0.89
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

ziftomenib (KOMZIFTI) is an FDA-listed pharmaceutical active ingredient. Associated with Kura Oncology. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN ziftomenib
Brand KOMZIFTI
Route ORAL
Formulation CAPSULE
Originator Kura Oncology

Approval history

Authority Status Date
FDA approved —

Pipeline programs

Search pipeline Sponsor programs
  1. KO-MEN-017 Phase 3 · Kura Oncology · NPM1-m and KMT2A-r Acute Myeloid Leukemia
  2. Ziftomenib Phase 3 · Kura Oncology · Acute Myeloid Leukemia (AML)
  3. Ziftomenib Phase 2 · Kura Oncology · Advanced Malignant Neoplasm
  4. Ziftomenib, Ziftomenib Phase 2 · Kura Oncology · Relapsed and/or refractory Acute Myeloid Leukemia
  5. KO-MEN-008 Phase 1 · Kura Oncology · Relapsed and/or refractory Acute Myeloid Leukemia
  6. Ziftomenib Phase 1 · Kura Oncology · Refractory Acute Leukemia
  7. Ziftomenib Phase 1 · Kura Oncology · AML
  8. Ziftomenib Phase 1 · Kura Oncology · KMT2A-rearranged

Related patents

Browse patents Kura Oncology patent hub

  1. US 12410184

    Crystalline forms of a menin inhibitor

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12377026

    Dental adhesive material kit

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12358210

    Resin composition for stereolithography

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12344691

    Resin composition for stereolithography

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12214061

    Adhesive composition for dental use

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12145888

    Zirconia molded body and pre-sintered body capable of being sintered in short time

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12138325

    Dental composition

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12115031

    Dental mill blank and dental prosthesis

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12030970

    Curable composition and stereolithographic resin composition comprising same

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12018011

    Macrocyclic compounds and compositions, and methods of preparing and using the same

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11981763

    Resin composition for stereolithographic modeling

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11944627

    Methods for treating hematological malignancies and Ewing's sarcoma

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11890359

    Zirconia composition, partially sintered material and sintered material and methods for production thereof, and laminate

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11813341

    Dental product with enhanced toughness

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11707346

    Dental mill blank and method for producing same

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11673898

    Substituted inhibitors of menin-MLL and methods of use

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11668704

    Degradation preventing means for immunoassay reagent containing insoluble carrier particles

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11607370

    Dental composition

    Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11547639

    Dental composition containing platinum nanoparticles

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11484477

    Dental adhesive material kit

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is ziftomenib?

ziftomenib (KOMZIFTI) is an FDA-listed pharmaceutical active ingredient. Associated with Kura Oncology. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for ziftomenib?

KOMZIFTI is a marketed brand name for ziftomenib. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ziftomenib?

ziftomenib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.